{"id":"W4389221984","doi":"10.1182/blood-2023-174750","title":"Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chlorambucil; Obinutuzumab; Internal medicine; Medicine; Hazard ratio; Neutropenia; Gastroenterology; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00224443,0.000529587,0.001428304,0.0003287679,0.0004378281,0.0006537529,0.0004661721,0.0006339949,0.001846581],"category_scores_gemma":[0.0009912839,0.0002231507,0.001090541,0.0004033239,0.0004212573,0.0007605014,0.0003527321,0.001537614,0.0004795257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000867513,"about_ca_system_score_gemma":0.0007416302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001396179,"about_ca_topic_score_gemma":0.001961053,"domain_scores_codex":[0.9994587,0.0001844641,0.00004364779,0.00009832336,0.00007168255,0.0001431718],"domain_scores_gemma":[0.9990023,0.0001817708,0.000299824,0.00008533126,0.00006613828,0.0003647255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8393404,0.02830256,0.04935795,0.0002646715,0.001513903,0.0001978145,0.0002536148,0.001358543,0.01191304,0.00008233524,0.001446442,0.06596886],"study_design_scores_gemma":[0.1201031,0.6456912,0.221194,0.00006079512,0.002223245,0.0004050427,0.0001616664,0.002088766,0.005017356,0.0002010318,0.002800199,0.00005362204],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979795,0.0006731807,0.00008224206,0.00004862162,0.00001944311,0.0002027678,0.0004525922,0.00001158502,0.0005301588],"genre_scores_gemma":[0.9975584,0.000351037,0.0001190837,0.0001123059,0.00004249236,0.000227266,0.0009667886,0.000003978646,0.0006187025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00224443,"threshold_uncertainty_score":0.01186979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0275422638931106,"score_gpt":0.2925937077638187,"score_spread":0.2650514438707081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}